GlassScriptPhysician profile
Peter A Santucci
NPI 1295804789
$17,832.02
in general payments reported to CMS, 2019-2025
15 companies · $2,451 in 2025
The $2,451 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $7,111 · 2021: $146 · 2022: $1,837 · 2023: $996 · 2024: $4,460 · 2025: $2,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,533 · Consulting Fee: $2,348 · Travel and Lodging: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,532.52 |
| Consulting Fee | $2,347.50 |
| Travel and Lodging | $1,026.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiofocus, INC. | $6,778.26 | 2020 | |
| Abbott Laboratories | $5,674.41 | 2019-2025 | Ensite, Ensite Precision, Aveir |
| Boston Scientific Corporation | $1,710.65 | 2019-2025 | Farapulse, Watchman Flx, General - Therapies |
| Biosense Webster, INC. | $1,197.97 | 2020-2025 | Carto 3, Qdot Micro Catheter |
| Biotronik INC. | $870.09 | 2019-2025 | |
| Medtronic, INC. | $832.06 | 2024-2025 | |
| Volta Medical INC | $457.78 | 2023 | Vx1 |
| Tempus Ai, INC | $121.57 | 2025 | Egg-Af |
| Medtronic Vascular, INC. | $73.20 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $28.47 | 2025 | |
| Atricure, INC. | $27.49 | 2024 | |
| Cardiva Medical, INC. | $23.77 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Janssen Pharmaceuticals, INC | $18.84 | 2019 | |
| Cordis US Corp. | $17.46 | 2024 | Mynx Control |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Santucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.